4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-019263
Chief Operating Officer gave up 4,057 shares (to pay taxes)
- Chief Operating Officer acquired 13,841 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2023-06-30 | Option exercise | +13,841 | 43,644 | D | ||
| Cittadine Andrew Chief Operating Officer | 2023-06-30 | Shares withheld for taxes | −4,057 | $0.86 | $3,469 | 39,587 | D |
| Derivatives | |||||||
| Cittadine Andrew Chief Operating Officer | 2023-06-30 | Option exercise · Restricted Stock Units | −13,841 | 109,080 | D | ||
Loading xslF345X04/rdgdoc.xml…